| Literature DB >> 24744461 |
Abstract
The aim of this study was to investigate the effect of 12 weeks of aerobic training on the serum levels of adiponectin and leptin and on inflammatory markers of coronary heart disease in obese men. Sixteen non-athlete obese men were randomly assigned to one of two experimental groups. The experimental group underwent aerobic training consisting of three sessions per week for 12 weeks, while the control group did not participate in the training programme during the study period. Five millilitres of venous blood was taken from each participant at the beginning of the study, during week six and at the end of week 12 to measure the levels of leptin, adiponectin, C-reactive protein, interleukin-6 and tumour necrosis factor-α. The findings showed that aerobic training led to decreases in the levels of CRP (P = 0.002), IL-6 (P = 0.001) and leptin (P = 0.003) and an increase in the level of adiponectin (P = 0.002) in the experimental group relative to the control group. In addition, the level of TNF-α decreased in the experimental group after the 12-week aerobic training period, although this change was not statistically significant. According to the results of this study, regular aerobic exercise decreases the potential risk of coronary heart disease by improving the plasma levels of IL-6, adiponectin, leptin and CRP. Additionally, aerobic exercise can be used as effective non-pharmacological treatment to prevent diseases.Entities:
Keywords: adiponectin; aerobic training; coronary heart disease; inflammatory markers; leptin; obese men
Year: 2013 PMID: 24744461 PMCID: PMC3944554 DOI: 10.5604/20831862.1029817
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
GENERAL CHARACTERISTICS OF THE SUBJECTS
| Group Variable | Experimental training group (N = 30) | Control group (N = 30) | F | P |
|---|---|---|---|---|
| Age (year) | 23.2 ± 2.5 | 22.7 ± 2.7 | 6.325 | 0.684 |
| Weight (kg) | 86.94 ± 5.8 | 88.76 ± 7.51 | 7.623 | 0.892 |
| Height (cm) | 170.13 ± 4.45 | 172.03 ± 6.47 | 6.146 | 0.712 |
|
| 36.14 ± 2.43 | 35.96 ± 1.78 | 1.697 | 0.541 |
| BMI | 30.05 ± 2.26 | 30.60 ± 2.45 | 2.06 | 0.522 |
| Body fat% | 23.89 ± 2.73 | 24.58 ± 2.61 | 3.52 | 0.683 |
CHANGES IN LEVELS OF INFLAMMATORY MARKERS, LEPTIN AND ADIPONECTIN IN EXPERIMENTAL AND CONTROL GROUP
| Variable | Group | Pre-test (week 0) | Mid-test (week 6) | Post-test (week 12) |
|---|---|---|---|---|
|
| Experimental group | 35.83 ± 2.3 | 37.93 ± 1.15 | 39.9 ± 1.8 |
| Body fat (%) | Experimental group | 23.74 ± 2.85 | 21.18 ± 1.49 | 19.78 ± 1.5 |
| CRP (pg · ml-1) | Experimental group | 1.70 ± 0.43 | 1.43 ± 0.4 | 1.06 ± 0.46 |
| TNF-a (pg · ml-1) | Experimental group | 13.32 ± 3.28 | 12.94 ± 3.11 | 10.16 ± 3.25 |
| IL-6 (pg · ml-1) | Experimental group | 7.42 ± 3.21 | 5.26 ± 3.45 | 1.93 ± 0.69 |
| Adiponectin (g · ml-1) | Experimental group | 16.75 ± 1.48 | 17.44 ± 1.78 | 18.43 ± 1.65 |
| Leptin (ng · ml-1) | Experimental group | 2.34 ± 0.27 | 2.30 ± 0.25 | 2.25 ± 0.22 |
Denotes a significant difference relative to the pre-test level (p < 0.05)
Denotes a significant difference between the experimental and control groups (p < 0.05)